Imperial College London


Faculty of MedicineSchool of Public Health

Senior Lecturer in Clinical Trial Statistics



+44 (0)20 7594 1218v.cornelius




111Stadium HouseWhite City Campus





Victoria Cornelius is Senior Lecturer in Medical Statistics and Clinical Trials at Imperial College London, Deputy Head of Statistics in Imperial Clinical Trials Unit (ICTU), and Joint Academic Lead for the Research Design Service (RDS) for West London (RDS London

 Victoria leads the Child Health portfolio and the Statistical Methods Research Group for ICTU (StatsCI). She has experience evaluating drug interventions across a broad range of therapeutic areas including asthma & allergy, mental health, and cancer. Her statistical research is in the use of time-to-event signal detection methods to identify adverse drug reactions and the selection and presentation of harm information in clinical trials. Victoria is passionate about translating best statistical practice into applied research to improve the quality of research. She has been involved and led national collaborative projects in laboratory studies, feasibility, and early phase clinical trials research to support methods translation. She established the NIHR Statistics Group in 2011 with the support of NOCRI which she subsequently co-led until March 2017.  Victoria supervises fellows undertaking PhDs in prediction modelling for post-cancer treatment anxiety and ADR signal detection methods in clinical trials. She also is the statistical supervisor for post-doctoral Fellows and trainees undertaking clinical trials, and statistical methods research. Victoria has been an associate editor for the journal Trials and Thorax. She is a member of the NIHR Academy Doctoral fellowship board.

Victoria obtained a BSc in Mathematics from Cardiff University in 1997, competed a PhD in Statistics in 2000 before joining the Centre for Statistics in Medicine at Oxford where she worked on cancer research projects. In 2005 she moved to the Drug Safety Research Unit where she was responsible for designing and analysing post-marketing surveillance studies to monitor the safety of medicines newly released to market. In 2009 she joined respiratory Biomedical Research Unit (BRU) at Southampton University Hospitals NHS Trust as a NIHR senior statistician working on allergy and respiratory translational research projects. In 2011 she took up to a Senior Lecturer in Medical Statistics position at King’s College London where she subsequently became the Deputy Director for Research Design Service London. She joined Imperial College London in February 2016.



Sayar Z, Czuprynska J, Patel JP, et al., 2019, What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial., J Thromb Thrombolysis, Vol:48, Pages:315-322

Cornelius V, Johnston CL, 2019, The enhanced peri-operative care for high-risk patients trial: an independent discussion and commentary, British Journal of Anaesthesia, ISSN:0007-0912

Gulati S, Dubois P, Carter B, et al., 2019, A Randomized Crossover Trial of Conventional vs Virtual Chromoendoscopy for Colitis Surveillance: Dysplasia Detection, Feasibility, and Patient Acceptability (CONVINCE)., Inflamm Bowel Dis, Vol:25, Pages:1096-1106

Ojji DB, Mayosi B, Francis V, et al., 2019, Comparison of dual therapies for lowering blood pressure in black Africans, New England Journal of Medicine, ISSN:0028-4793

Gimeno H, Brown RG, Lin J-P, et al., 2019, Cognitive approach to rehabilitation in children with hyperkinetic movement disorders post-DBS, Neurology, Vol:92, ISSN:0028-3878, Pages:E1212-E1224

More Publications